Eatherton; Andrew John
Patent Applications and Registrations
Patent applications and USPTO patent grants for Eatherton; Andrew John.The latest application filed is for "heteroaryl compounds that inhibit g12c mutant ras proteins".
- Eatherton; Andrew John - Cambridge GB
- Eatherton; Andrew John - Middlesex N/A GB
- Eatherton; Andrew John - Brentford GB
- Eatherton; Andrew John - Essex GB
- Eatherton; Andrew John - Welwyn GB
- Eatherton; Andrew John - Harlow GB
- Eatherton; Andrew John - Hertfordshire GB
| Patent | Date |
|---|---|
| Tetracyclic heteroaryl compounds Grant 11,407,765 - Kettle , et al. August 9, 2 | 2022-08-09 |
| Heteroaryl Compounds That Inhibit G12c Mutant Ras Proteins App 20220127281 - KETTLE; Jason Grant ; et al. | 2022-04-28 |
| Tetracyclic Heteroaryl Compounds App 20210221823 - KETTLE; Jason Grant ; et al. | 2021-07-22 |
| Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer App 20210147416 - Barlaam; Bernard Christophe ; et al. | 2021-05-20 |
| Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer Grant 10,882,858 - Barlaam , et al. January 5, 2 | 2021-01-05 |
| Heteroaryl Compounds That Inhibit G12c Mutant Ras Proteins App 20200109153 - KETTLE; Jason Grant ; et al. | 2020-04-09 |
| Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer App 20200102302 - Barlaam; Bernard Christophe ; et al. | 2020-04-02 |
| Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer Grant 10,457,679 - Barlaam , et al. Oc | 2019-10-29 |
| Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer App 20180318287 - PIKE; Kurt Gordon ; et al. | 2018-11-08 |
| Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer App 20180280377 - PIKE; Kurt Gordon ; et al. | 2018-10-04 |
| Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer App 20180141943 - Barlaam; Bernard Christophe ; et al. | 2018-05-24 |
| Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer App 20170081325 - Barlaam; Bernard Christophe ; et al. | 2017-03-23 |
| 2-(benzyloxy) benzamides as LRRK2 kinase inhibitors Grant 9,365,551 - Andreotti , et al. June 14, 2 | 2016-06-14 |
| Compounds Grant 8,778,939 - Nichols , et al. July 15, 2 | 2014-07-15 |
| 2-(benzyloxy) Benzamides As Lrrk2 Kinase Inhibitors App 20130225584 - Andreotti; Daniele ; et al. | 2013-08-29 |
| Novel Compounds App 20120184553 - Nichols; Paula Louise ; et al. | 2012-07-19 |
| Benzofuran Compounds Useful In The Treatment Of Conditions Mediated By The Action Of Pge2 At The Ep1 Receptor App 20100056527 - Eatherton; Andrew John ; et al. | 2010-03-04 |
| Pyrimidine Derivatives And Their Use As CB2 Modulators App 20100041654 - Eatherton; Andrew John ; et al. | 2010-02-18 |
| Pyrimidine derivatives and their use as CB2 modulators Grant 7,635,701 - Eatherton , et al. December 22, 2 | 2009-12-22 |
| 2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modulators for the Treatment of Immune or Inflammatory Disorders App 20090264452 - Eatherton; Andrew John ; et al. | 2009-10-22 |
| Pyrrolopyridine derivatives Grant 7,589,206 - Eatherton , et al. September 15, 2 | 2009-09-15 |
| Compounds App 20090018128 - Eatherton; Andrew John ; et al. | 2009-01-15 |
| Pyridine Derivatives and Their Use as Cb2 Receptor Modulators App 20080280868 - Eatherton; Andrew John ; et al. | 2008-11-13 |
| Pyrimidine Derivatives as Cannabinoid Receptor Modulators App 20080261977 - Eatherton; Andrew John ; et al. | 2008-10-23 |
| Imidazopyridine Derivatives as Cannabinoid Receptor Ligands App 20080221097 - Eatherton; Andrew John ; et al. | 2008-09-11 |
| Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine App 20080132505 - Brown; Andrew James ; et al. | 2008-06-05 |
| Pyrrolopyridine Derivatives App 20070219229 - Eatherton; Andrew John ; et al. | 2007-09-20 |
| Pyridine derivatives as cb2 receptor modulators App 20070129367 - Eatherton; Andrew John ; et al. | 2007-06-07 |
| Pyrimidine derivatives and their use as CB2 modulators App 20060293354 - Eatherton; Andrew John | 2006-12-28 |
| Pyrimidine compounds App 20060247261 - Eatherton; Andrew John ; et al. | 2006-11-02 |
| Pyridine derivatives as cb2 receptor modulators App 20060240048 - Eatherton; Andrew John ; et al. | 2006-10-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 